GetTopicDetailResponse(id=b9bf55e735a, topicName=抗血管生成治療, introduction=抗血管生成治療, content=null, image=null, comments=0, allHits=1255, url=https://h5.medsci.cn/topic?id=55773, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=20337, tagList=[TagDto(tagId=20337, tagName=抗血管生成治療)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2260465, encodeId=a340226046526, content=<a href='/topic/show?id=b9bf55e735a' target=_blank style='color:#2F92EE;'>#抗血管生成治療#</a> <a href='/topic/show?id=57a483098c9' target=_blank style='color:#2F92EE;'>#腫瘤血管生成#</a>, objectTitle=腫瘤血管生成與抗血管生成治療, objectType=article, longId=871924, objectId=9b3a8e1924b5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/confident-experienced-doctor-NJVKHS4.jpg, objectUrl=/article/show_article.do?id=9b3a8e1924b5, replyNumber=0, likeNumber=44, createdTime=2025-04-14, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b3a8e1924b5, moduleTitle=腫瘤血管生成與抗血管生成治療, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9b3a8e1924b5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2236248, encodeId=8efb22362488b, content=<a href='/topic/show?id=6ba655658cc' target=_blank style='color:#2F92EE;'>#抗腫瘤血管生成#</a> <a href='/topic/show?id=b9bf55e735a' target=_blank style='color:#2F92EE;'>#抗血管生成治療#</a>, objectTitle=腫瘤的血管生成信號通路與抗血管生成治療, objectType=article, longId=796061, objectId=54b5e960611b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241105/1730803169148_8538692.jpg, objectUrl=/article/show_article.do?id=54b5e960611b, replyNumber=0, likeNumber=52, createdTime=2024-11-10, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=54b5e960611b, moduleTitle=腫瘤的血管生成信號通路與抗血管生成治療, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=54b5e960611b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2212843, encodeId=e09f22128437f, content=<a href='/topic/show?id=5e2e4e08988' target=_blank style='color:#2F92EE;'>#小細胞肺癌#</a> <a href='/topic/show?id=b9bf55e735a' target=_blank style='color:#2F92EE;'>#抗血管生成治療#</a>, objectTitle=孟凡路：廣泛期小細胞肺癌一線抗血管生成治療進展, objectType=article, longId=832659, objectId=faf383265953, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240702/1719906087539_1608702.png, objectUrl=/article/show_article.do?id=faf383265953, replyNumber=0, likeNumber=136, createdTime=2024-07-02, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=faf383265953, moduleTitle=孟凡路：廣泛期小細胞肺癌一線抗血管生成治療進展, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=faf383265953)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
